Stent thrombosis in early-generation drug-eluting stents versus newer-generation everolimus-eluting stent assorted by LVEF-Reference-Cited by-同舟云学术

Stent thrombosis in early-generation drug-eluting stents versus newer-generation everolimus-eluting stent assorted by LVEF

Published:2014-08-27 Issue:1 Volume:101 Page:50-57
ISSN:1355-6037
Container-title:Heart
language:en
Short-container-title:Heart

Author:

van Boven Nick,Windecker Stephan,Umans Victor A,van Domburg Ron T,Kardys Isabella,Akkerhuis K Martijn,van Geuns Robbert-Jan,Serruys Patrick W,Magro Michael,Räber Lorenz,Boersma Eric

Publisher

BMJ

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease;Stone;N Engl J Med,2004

2. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial;Stone;JAMA,2005

3. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery;Moses;N Engl J Med,2003

4. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization;Morice;N Engl J Med,2002

5. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents;Kastrati;N Engl J Med,2007

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence, Predictors, and Outcomes of Acute and Sub-acute Stent Thrombosis after Emergency Percutaneous Coronary Revascularization with Drug-Eluting Stents: A Prospective Observational Study;Global Heart;2022

2. REabsorbable vs. DUrable Polymer Drug-Eluting Stents in All-Comer PatiEnts: the REDUCE registry;Coronary Artery Disease;2020-11-20

3. A scoring system to predict the occurrence of very late stent thrombosis following percutaneous coronary intervention for acute coronary syndrome;Scientific Reports;2020-04-14

4. Very Late Stent Thrombosis in Drug-Eluting Stents New Observations and Clinical Implications;Cardiology in Review;2019-11

5. A rapamycin derivative, biolimus, preferentially activates autophagy in vascular smooth muscle cells;Scientific Reports;2018-11-08